Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1897 1
1998 1
2002 3
2003 6
2004 5
2005 6
2006 6
2007 3
2008 6
2009 5
2010 4
2011 9
2012 4
2013 10
2014 3
2015 4
2016 13
2017 12
2018 14
2019 16
2020 16
2021 14
2022 11
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
ARTISTRY-7: phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer.
Herzog TJ, Hays JL, Barlin JN, Buscema J, Cloven NG, Kong LR, Tyagi NK, Lanneau GS, Long BJ, Marsh RL, Seward SM, Starks DC, Welch S, Moore KN, Konstantinopoulos PA, Gilbert L, Monk BJ, O'Malley DM, Chen X, Dalal R, Coleman RL, Sehouli J. Herzog TJ, et al. Among authors: hays jl. Future Oncol. 2023 Jul;19(23):1577-1591. doi: 10.2217/fon-2023-0246. Epub 2023 Jun 19. Future Oncol. 2023. PMID: 37334673 Free article.
Developmental roadmap for antimicrobial susceptibility testing systems.
van Belkum A, Bachmann TT, Lüdke G, Lisby JG, Kahlmeter G, Mohess A, Becker K, Hays JP, Woodford N, Mitsakakis K, Moran-Gilad J, Vila J, Peter H, Rex JH, Dunne WM Jr; JPIAMR AMR-RDT Working Group on Antimicrobial Resistance and Rapid Diagnostic Testing. van Belkum A, et al. Among authors: hays jp. Nat Rev Microbiol. 2019 Jan;17(1):51-62. doi: 10.1038/s41579-018-0098-9. Nat Rev Microbiol. 2019. PMID: 30333569 Free PMC article. Review.
Olaparib in the management of ovarian cancer.
Bixel K, Hays JL. Bixel K, et al. Among authors: hays jl. Pharmgenomics Pers Med. 2015 Aug 7;8:127-35. doi: 10.2147/PGPM.S62809. eCollection 2015. Pharmgenomics Pers Med. 2015. PMID: 26309417 Free PMC article. Review.
Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics.
Murugaiyan J, Kumar PA, Rao GS, Iskandar K, Hawser S, Hays JP, Mohsen Y, Adukkadukkam S, Awuah WA, Jose RAM, Sylvia N, Nansubuga EP, Tilocca B, Roncada P, Roson-Calero N, Moreno-Morales J, Amin R, Kumar BK, Kumar A, Toufik AR, Zaw TN, Akinwotu OO, Satyaseela MP, van Dongen MBM. Murugaiyan J, et al. Among authors: hays jp. Antibiotics (Basel). 2022 Feb 4;11(2):200. doi: 10.3390/antibiotics11020200. Antibiotics (Basel). 2022. PMID: 35203804 Free PMC article. Review.
Molecular aspects of Moraxella catarrhalis pathogenesis.
de Vries SP, Bootsma HJ, Hays JP, Hermans PW. de Vries SP, et al. Among authors: hays jp. Microbiol Mol Biol Rev. 2009 Sep;73(3):389-406, Table of Contents. doi: 10.1128/MMBR.00007-09. Microbiol Mol Biol Rev. 2009. PMID: 19721084 Free PMC article. Review.
168 results